Marlan D. Walker

CIK: 0001820187

Transaction Breakdown

Open Market Buys (P)3 (37.5%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)4 (50.0%)

Derivative conversions

Awards (A)1 (12.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TXMD

TherapeuticsMD, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

TXMD
TherapeuticsMD, Inc.
Nov 3, 2025
Award(A)
Non-Qualified Stock Option (right to buy)
Direct
67.5K shares-
TXMD
TherapeuticsMD, Inc.
Apr 14, 2025
Purchase(P)
Direct
490 shares at avg. $1.00$489.265
TXMD
TherapeuticsMD, Inc.
Apr 10, 2025
Purchase(P)
Direct
1.2K shares at avg. $0.86$1K
TXMD
TherapeuticsMD, Inc.
Apr 9, 2025
Purchase(P)
Direct
1.1K shares at avg. $0.87$993.659
TXMD
TherapeuticsMD, Inc.
Feb 18, 2025
Exercise(M)
Direct
3.5K shares-
TXMD
TherapeuticsMD, Inc.
Feb 18, 2025
Exercise(M)
Direct
2.3K shares-
TXMD
TherapeuticsMD, Inc.
Feb 18, 2025
Exercise(M)
Direct
770 shares-
TXMD
TherapeuticsMD, Inc.
Feb 18, 2025
Exercise(M)
Direct
1.7K shares-

		Type	Shares	Price		Ownership
Nov 3, 2025	TXMD TherapeuticsMD, Inc.	Award(A) Non-Qualified Stock Option (right to buy)	67,492	-	-	Direct
Apr 14, 2025	TXMD TherapeuticsMD, Inc.	Purchase(P)	490	$1.00	$489	Direct
Apr 10, 2025	TXMD TherapeuticsMD, Inc.	Purchase(P)	1,167	$0.86	$1,000	Direct
Apr 9, 2025	TXMD TherapeuticsMD, Inc.	Purchase(P)	1,136	$0.87	$994	Direct
Feb 18, 2025	TXMD TherapeuticsMD, Inc.	Exercise(M)	3,467	-	-	Direct
Feb 18, 2025	TXMD TherapeuticsMD, Inc.	Exercise(M)	2,311	-	-	Direct
Feb 18, 2025	TXMD TherapeuticsMD, Inc.	Exercise(M)	770	-	-	Direct
Feb 18, 2025	TXMD TherapeuticsMD, Inc.	Exercise(M)	1,733	-	-	Direct

1-8 of 8 transactions

About Walker Marlan D

Walker Marlan D (SEC CIK 0001820187) files insider reports with the SEC as Chief Executive Officer of TherapeuticsMD, Inc. (TXMD).

Signal8 holds 4 ownership filings by Walker Marlan D, all Form 4s, filed between Feb 20, 2025 and Nov 5, 2025. Those filings report 8 transactions, from Feb 18, 2025 to Nov 3, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Walker Marlan D's filings is in BOCA RATON, FL.

Recent filings by Walker Marlan D

Nov 3, 2025: Grant or award of TXMD derivative securities (Form 4, code A).
Apr 14, 2025: Open-market purchase of TXMD shares (Form 4, code P).
Apr 10, 2025: Open-market purchase of TXMD shares (Form 4, code P).
Apr 9, 2025: Open-market purchase of TXMD shares (Form 4, code P).
Feb 18, 2025: Option exercises of TXMD shares (4 lines, Form 4, code M).

Other insiders filing for TherapeuticsMD, Inc. (TXMD)

Thompson Tommy G, Director
Naughton Gail K, Director
Collins Cooper C., Director

How to read Form 4 transaction codes